“Extrauterine growth restriction” and “postnatal growth failure” are misnomers for preterm infants

2020 ◽  
Vol 40 (5) ◽  
pp. 704-714 ◽  
Author(s):  
Tanis R. Fenton ◽  
Barbara Cormack ◽  
Dena Goldberg ◽  
Roseann Nasser ◽  
Belal Alshaikh ◽  
...  
2019 ◽  
Vol 38 (1) ◽  
pp. 27-33 ◽  
Author(s):  
Kari Bonnar ◽  
Debbie Fraser

Extrauterine growth restriction (EUGR) affects a significant number of very low birth weight (VLBW) infants and has the potential to impact neurodevelopmental outcome as well as other aspects of long-term health. More aggressive nutritional approaches have reduced the incidence of postnatal growth failure but many questions remain about the expected rate of growth for very preterm infants, the best ways to measure growth velocity, and the optimal approaches to supporting growth. This article examines some of the outstanding issues regarding postnatal growth failure and summarizes current practice recommendations.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Noelle E. Younge ◽  
Christopher B. Newgard ◽  
C. Michael Cotten ◽  
Ronald N. Goldberg ◽  
Michael J. Muehlbauer ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Alison Chu ◽  
Yasmeen Dhindsa ◽  
Myung Shin Sim ◽  
Marie Altendahl ◽  
Irena Tsui

Abstract Low birthweight and decreased postnatal weight gain are known predictors of worse retinopathy of prematurity (ROP) but the role of prenatal growth patterns in ROP remains inconclusive. To distinguish small for gestational age (SGA) from intrauterine growth restriction (IUGR) as independent predictors of ROP, we performed a retrospective cohort study of patients who received ROP screening examinations at a level IV neonatal intensive care unit over a 7-year period. Data on IUGR and SGA status, worst stage of and need for treatment for ROP, and postnatal growth was obtained. 343 infants were included for analysis (mean gestational age = 28.6 weeks and birth weight = 1138.2 g). IUGR infants were more likely to have a worse stage of ROP and treatment-requiring ROP (both p < 0.0001) compared to non-IUGR infants. IUGR infants were more likely to be older at worst stage of ROP (p < 0.0001) and to develop postnatal growth failure (p = 0.01) than non-IUGR infants. Independent of postnatal growth failure status, IUGR infants had a 4–5 × increased risk of needing ROP treatment (p < 0.001) compared to non-IUGR infants. SGA versus appropriate for gestational age infants did not demonstrate differences in retinopathy outcomes, age at worst ROP stage, or postnatal growth failure. These findings emphasize the importance of prenatal growth on ROP development.


2008 ◽  
Vol 84 (8) ◽  
pp. 555-559 ◽  
Author(s):  
Paola Roggero ◽  
Maria Lorella Giannì ◽  
Orsola Amato ◽  
Anna Orsi ◽  
Pasqua Piemontese ◽  
...  

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1188
Author(s):  
Danuta Dudzik ◽  
Isabel Iglesias Platas ◽  
Montserrat Izquierdo Renau ◽  
Carla Balcells Esponera ◽  
Beatriz del Rey Hurtado de Mendoza ◽  
...  

Very preterm infants (VPI, born at or before 32 weeks of gestation) are at risk of adverse health outcomes, from which they might be partially protected with appropriate postnatal nutrition and growth. Metabolic processes or biochemical markers associated to extrauterine growth restriction (EUGR) have not been identified. We applied untargeted metabolomics to plasma samples of VPI with adequate weight for gestational age at birth and with different growth trajectories (29 well-grown, 22 EUGR) at the time of hospital discharge. A multivariate analysis showed significantly higher levels of amino-acids in well-grown patients. Other metabolites were also identified as statistically significant in the comparison between groups. Relevant differences (with corrections for multiple comparison) were found in levels of glycerophospholipids, sphingolipids and other lipids. Levels of many of the biochemical species decreased progressively as the level of growth restriction increased in severity. In conclusion, an untargeted metabolomic approach uncovered previously unknown differences in the levels of a range of plasma metabolites between well grown and EUGR infants at the time of discharge. Our findings open speculation about pathways involved in growth failure in preterm infants and the long-term relevance of this metabolic differences, as well as helping in the definition of potential biomarkers.


2002 ◽  
Vol 7 (suppl_A) ◽  
pp. 46A-47A
Author(s):  
P Shah ◽  
K Wong ◽  
S Merko ◽  
R Bishara ◽  
M Dunn ◽  
...  

2014 ◽  
pp. 41-60 ◽  
Author(s):  
Enrico Bertino ◽  
Paula Di Nicola ◽  
Luciara Occhi ◽  
Giovanna Prandi ◽  
Giorgio Gilli

2006 ◽  
Vol 34 (6) ◽  
Author(s):  
Prakesh S. Shah ◽  
Kit Y. Wong ◽  
Susan Merko ◽  
Roshine Bishara ◽  
Michael Dunn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document